跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,017 条关于
“BCL2 inhibitors”
全部
14,017
临床试验
6,536
药物
3,259
机构
8
资讯
4,214
2年前
Managing Toxicities in CLL Treatment: Expert Insights on BCL2 and BTK Inhibitor Selection
去年
InnoCare's BCL2 Inhibitor ICP-248 Combination Therapy Advances to Phase III Trial for First-line CLL/SLL Treatment in China
去年
Breyanzi Plus Ibrutinib Shows Promise in High-Risk CLL Patients
去年
BGB-16673 Shows Promise in Relapsed/Refractory CLL/SLL and Waldenström Macroglobulinemia
10个月前
Cancer Drug Venetoclax Shows 100% Efficacy in Preventing ALS Progression in Preclinical Study
去年
Chemotherapy-Free Regimens and CAR-T Therapies Transform B-Cell Malignancy Treatment Paradigms
2年前
Emerging BTK Degraders Show Promise in Treating Resistant B-Cell Malignancies
2年前
FDA Grants Fast Track Designation to Nurix Therapeutics' NX-5948 for Relapsed/Refractory CLL/SLL
3年前
Pirtobrutinib Shows Promising Efficacy in CLL/SLL Patients After BTK Inhibitor Failure
2个月前
Biomarker-Guided Drug Combinations May Overcome Treatment Resistance in Advanced Melanoma
第 1 页,共 422 页
上一页
下一页